Study With Aminophylline to Attenuate of the Side Effects of Regadenoson

Clinical trial NCT01250496 · TERMINATED

Trial details

NCT number: NCT01250496
Sponsor: Rush University Medical Center
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Patients Being Assessed With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson, Lexiscan

Start date: 2010-11-01
Primary completion: 2011-11-01
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.